Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Asahi Sato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0985-9394; OpenAlex author ID A5072673296. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective S… Co-author DOI 10.1097/sla.0000000000007052↗
  2. Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits. Co-author DOI 10.1016/j.pan.2025.04.012↗
  3. Association between patient's age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1016/j.asjsur.2022.10.009↗
  4. Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase… Co-author DOI 10.1186/s12885-022-09244-6↗
  5. Time-frequency analysis of serum with proton nuclear magnetic resonance for diagnosis of pancreatic cancer. Co-author DOI 10.1038/s41598-020-79087-3↗
  6. A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement. Co-author DOI 10.21873/anticanres.12172↗
  7. Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors. Co-author DOI 10.1007/s00595-016-1310-z↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshihiko Masui · 6 shared papers, 2016–2026 · strength 0.75
  2. Kazuyuki Nagai · 4 shared papers, 2022–2026 · strength 0.72
  3. Etsuro Hatano · 4 shared papers, 2022–2026 · strength 0.72
  4. Yuichiro Uchida · 4 shared papers, 2017–2026 · strength 0.57
  5. Kei Yamane · 2 shared papers, 2025–2026 · strength 0.41
  6. Shinji Üemoto · 4 shared papers, 2016–2022 · strength 0.35
  7. Michio Yoshimura · 2 shared papers, 2022–2025 · strength 0.32
  8. Akihisa Fukuda · 2 shared papers, 2022–2025 · strength 0.32
  9. Kyoichi Takaori · 3 shared papers, 2016–2022 · strength 0.23
  10. Shintaro Yagi · 1 shared paper, 2026 · strength 0.21
  11. Masato Narita · 1 shared paper, 2026 · strength 0.21
  12. Naoya Sasaki · 1 shared paper, 2026 · strength 0.21
  13. Yusuke Okamura · 1 shared paper, 2026 · strength 0.21
  14. Takahiro Iwai · 1 shared paper, 2025 · strength 0.20
  15. Junichi Matsubara · 1 shared paper, 2025 · strength 0.20
  16. Masashi Kanai · 2 shared papers, 2017–2022 · strength 0.17
  17. Takashi Mizowaki · 1 shared paper, 2022 · strength 0.11
  18. Keiko Shibuya · 1 shared paper, 2017 · strength 0.06
  19. Yökö Gotö · 1 shared paper, 2017 · strength 0.06
  20. Yuzo Kodama · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.